Promega

VEGF Bioassay

#G7940 · elisa

62
Evidence Score · Well-Established
Used by 80 independent labs across 98 papers. How we score this →
43
Citing papers
1.2k
Combined citations
Supplier page Find this product

Research areas

Monoclonal and Polyclonal Antibodies Research15SARS-CoV-2 and COVID-19 Research13Animal Virus Infections Studies8CAR-T cell therapy research8Immunotherapy and Immune Responses7Cancer Immunotherapy and Biomarkers6Viral gastroenteritis research and epidemiology5Immune Cell Function and Interaction4

Papers citing this product

1
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Nature·2021·582 cit.·DOI
2
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia
Journal of Hematology & Oncology·2017·62 cit.·DOI
3
Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction
Communications Biology·2022·52 cit.·DOI
4
A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
Journal of Pharmacology and Experimental Therapeutics·2019·52 cit.·DOI
5
Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers
Molecular Cancer Therapeutics·2023·41 cit.·DOI
6
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma
Clinical Cancer Research·2023·40 cit.·DOI
7
CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
Journal for ImmunoTherapy of Cancer·2023·39 cit.·DOI
8
Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials
medRxiv·2020·33 cit.·DOI
9
Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants
Nature Communications·2024·30 cit.·DOI
10
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
bioRxiv (Cold Spring Harbor Laboratory)·2021·21 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
VEGF BioassayPromega62—50
VEGF BioassayPromega62—5
VEGF BioassayPromega62—2
VEGF BioassayPromega62——
VEGF BioassayPromega62——
VEGF BioassayPromega62——

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.